29/08/2014 16:24:38 Free Membership Login

Corcept Therapeutics News (NASDAQ:CORT)

DateTimeSource
Headline
06/20/20144:14PMMWUS/ CORRECTION - Corcept Therapeutics
/ CORRECTION - Corcept Therapeutics CHICAGO, IL--(Marketwired - Jun 20, 2014) - In the news release, "New Research on Corcept's Korlym(R) for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014," issued Thursday, June 19, 2014 by Corcept Therapeutics (NASDAQ: CORT), we are advised by the company that the... More...>>
06/19/20149:00AMMWUSNew Research on Corcept's Korlym(R) for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014
New Research on Corcept's Korlym(R) for Patients With Cushing's Syndrome to Be Presented at ICE/ENDO 2014 New Data Includes Results of a Long-Term Extension Phase of Corcept's Multicenter, Open-Label SEISMIC Study CHICAGO, IL--(Marketwired - Jun 19, 2014) -  Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical... More...>>
05/08/20144:35PMZACKSCorcept Plunges on Study Results - Analyst Blog
Shares of Corcept Therapeutics Inc. (CORT) were down 50.5% after the company announced that it will discontinue the study on Korlym (study 14) for the treatment of psychotic depression after an interim analysis (n=226) revealed that the study has failed to meet its primary endpoint, which was a rapid and sustained reduction... More...>>
05/07/20148:30AMMWUSCorcept Therapeutics Announces First Quarter 2014 Financial Results
Corcept Therapeutics Announces First Quarter 2014 Financial Results Interim Analysis of Data From Phase 3 Trial of Mifepristone for the Treatment of Psychotic Depression Fails to Demonstrate Efficacy With Statistical Significance MENLO PARK, CA--(Marketwired - May 7, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT... More...>>
04/30/20144:30PMMWUSCorcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call
Corcept Therapeutics to Announce First Quarter Financial Results and Corporate Update and Host Conference Call MENLO PARK, CA--(Marketwired - Apr 30, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 7, 2014. The... More...>>
04/10/20148:21AMPRNUSBrinson Patrick Re-launches Research Department
Brinson Patrick Re-launches Research Department -- Firm Initiates Coverage on Corcept Therapeutics, Ligand Pharmaceuticals, MannKind Corporation, Opexa Therapeutics and Rexahn Pharmaceuticals -- PR Newswire NEW YORK, April 10, 2014 NEW YORK, April 10, 2014 /PRNewswire/ -- Brinson Patrick Securities Corporation  ("Brinson... More...>>
04/02/201412:15PMMWUSUS Oncology Research Joins Corcept Therapeutics' Phase I Breast Cancer Study
US Oncology Research Joins Corcept Therapeutics' Phase I Breast Cancer Study Multi-Center Study Now Enrolling Patients at US Oncology Research Affiliated Sites in Texas and Virginia MENLO PARK, CA and THE WOODLANDS, TX--(Marketwired - Apr 2, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company... More...>>
03/05/20149:00AMMWUSCorcept Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results
Corcept Therapeutics Announces Fourth Quarter and Full Year 2013 Financial Results MENLO PARK, CA--(Marketwired - Mar 5, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric... More...>>
01/30/20144:05PMMWUSCorcept Therapeutics Announces Fourth Quarter, Full Year 2013 Revenue and Provides 2014 Outlook
Corcept Therapeutics Announces Fourth Quarter, Full Year 2013 Revenue and Provides 2014 Outlook MENLO PARK, CA--(Marketwired - Jan 30, 2014) - Corcept Therapeutics Incorporated (NASDAQ: CORT) Fourth quarter 2013 revenue up 56% over third quarter 2013 revenue Company anticipates Korlym 2014 revenue to grow to a range of... More...>>
01/27/20148:30AMMWUSCorcept Therapeutics to Announce Fourth Quarter and Full Year Revenue and Corporate Update and Host Conference Call
Corcept Therapeutics to Announce Fourth Quarter and Full Year Revenue and Corporate Update and Host Conference Call MENLO PARK, CA--(Marketwired - Jan 27, 2014) -  Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full year 2013 revenue on January 30, 2014. The Company... More...>>
12/16/20135:05PMZACKSPipeline Progress at Corcept - Analyst Blog
Corcept Therapeutics Inc.'s (CORT) key objective in 2014 is the successful commercialization of its only approved product, Korlym. Corcept launched Korlym in the U.S in Apr 2012. Korlym is approved in the U.S. and the EU as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism... More...>>
12/12/20138:30AMMWUSCorcept Therapeutics Announces Oncology Development Program
Corcept Therapeutics Announces Oncology Development Program Five of Eight Patients With Relapsed, Metastatic Triple-Negative Breast Cancer (TNBC) Experienced a Partial or Complete Response With Mifepristone and Chemotherapy Combination According to Data Presented at the San Antonio Breast Cancer Symposium 2013; Company... More...>>
11/07/20134:38PMMWUSCorcept Therapeutics Announces Third Quarter 2013 Financial Results and Corporate Update
Corcept Therapeutics Announces Third Quarter 2013 Financial Results and Corporate Update MENLO PARK, CA--(Marketwired - Nov 7, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and... More...>>
11/04/20135:00PMMWUSCorcept Therapeutics to Announce Third Quarter 2013 Financial Results and Host Conference Call
Corcept Therapeutics to Announce Third Quarter 2013 Financial Results and Host Conference Call MENLO PARK, CA--(Marketwired - Nov 4, 2013) - Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter 2013 financial results on November 7, 2013. The Company will host a conference call that... More...>>
08/08/20134:05PMMWUSCorcept Therapeutics Announces Second Quarter 2013 Financial Results and Corporate Update
Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders, today reported its financial results for the quarter ended June 30, 2013. Second Quarter Financial Results Recognized... More...>>
08/01/20134:05PMMWUSCorcept Therapeutics to Announce Second Quarter 2013 Financial Results and Host Conference Call
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report second quarter 2013 financial results on August 8, 2013. The Company will host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information To participate, dial 1-888-771-4371 from the United States... More...>>
07/24/20139:00AMMWUSCorcept Therapeutics Announces Partnership With Idis for Global Access to Korlym(R)
Corcept Therapeutics Incorporated (NASDAQ: CORT) announced today that Korlym® (mifepristone) 300 mg Tablets is available to patients outside of the United States through an Idis Access Program. Idis Access Programs enable patients around the world to be prescribed investigational or approved drugs prior to their commercial... More...>>
05/07/20137:40AMZACKSWider-than-Expected Loss at Corcept - Analyst Blog
Corcept Therapeutics Inc. (CORT) posted a loss per share of 11 cents in the first quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 10 cents. In the year-ago quarter, Corcept reported a loss of 13 cents. Corcept generated revenues of $1.7 million in the first quarter of 2013, missing the Zacks Consensus... More...>>
05/02/20134:05PMMWUSCorcept Therapeutics Announces First Quarter 2013 Financial Results
Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders, today reported its financial results for the quarter ended March 31, 2013. First Quarter Financial Results For... More...>>
04/26/20139:00AMMWUSCorcept Therapeutics to Announce First Quarter 2013 Financial Results and Host Conference Call
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter 2013 financial results on May 2, 2013. The Company will host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information To participate, dial 1-888-771-4371 from the United States... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq cort140829 16:24